Vernal keratoconjunctivitis Market
Vernal Keratoconjunctivitis may represent as 3% of serious ophthalmic disease. In addition, the prevalence is about 1 in 5000 cases of eye disease in Northern Europe and North America.

A Japanese epidemiologic study (Uchio EKimura et al, 2008) showed that VKC accounted for 4% of all ocular allergies with a low mean age of patients and severe clinical presentation.

According to the World Allergy Organization, males are more frequently affected than females, with a ratio of 3:1. The disease usually begins before the age of 10 years and remits at the time of puberty, although the age of affected individuals ranges from 3 to 25 years of age.

For more information on Vernal keratoconjunctivitis Market, visit:
https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market